Trial intelligence / Profile preview

Topical tranexamic acid for hidden blood loss in elderly intertrochanteric fracture surgery

ChiCTR1800014309Phase 4Recruiting

Sponsor
The People's Hospital of Leiyang
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of tranexamic acid in intertrochanteric fracture (2 arms), sponsored by The People's Hospital of Leiyang. Primary endpoint: hidden blood loss. Started Jan 2018; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

intertrochanteric fracture

Beyond the preview

Go deeper on ChiCTR1800014309.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800014309.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call